home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Webinar On FDA Good Laboratory Practice

 
  August 07, 2015  
     
 


Compliance Trainings, Online
2015-09-01


Description :

Understanding the regulatory requirements set out under good laboratory practice (GLP) regulations is important so that the GLP requirements can be adequately implemented, helping to streamline regulatory processes and to save a significant time and effort during the process.

This webinar is intended to help industry get better familiar with the GLP requirements from practical perspectives.

This 60-min presentation will provide great opportunities to get familiar with GLP regulatory and compliance requirements applicable to many industries (drugs, biologics/biosimilars, and medical devices including IVDs, etc.).

This webinar is a must for professionals who are involved in studies subject to GLP regulations including anyone interested in the topics from other industry.

Areas Covered in the Session :

Laws and Regulations

Definitions

GLP Regulations

GLP Requirements

Compliance to GLP Regulations

FDA Guidance and Standards

Best Practices: Dos and Don’ts

Speaker’s Recommendation and Suggestions on PASS-IT Solutions

Who Will Benefit:

R&D

Quality

Regulatory Affairs

Compliance Officers

CEOs

VPs

Attorneys

Complainant Managers

Managers (RA, QA/QC, CA)

Consultants

Contractors and Subcontractors

 

Anyone interested in the topic

 
 
Organized by: Compliance Trainings
Invited Speakers:

Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Doctor (www.RegulatoryDoctor.com). Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past seven years. 

 
Deadline for Abstracts: 2015-08-31
 
Registration:

For more information about this event please visit

 

https://compliancetrainings.com/SiteEngine/ProductDetailView.aspx?id=FDB1680

E-mail: suzzane.d@compliancetrainings.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.